Clinical Response to Olaparib in a Patient With Leptomeningeal Carcinomatosis in Newly Diagnosed Breast Cancer With Germline <i>BRCA2</i> Mutation.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 38991180.
- Also identified by DOI 10.1200/PO.24.00063.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Case of LMC in a BRCA2-mutated breast cancer patient shows clinical improvement with Olaparib therapy.
Medical subject headings
- Phthalazines
- Breast Neoplasms
- Piperazines
- Germ-Line Mutation
- BRCA2 Protein
- Meningeal Carcinomatosis